Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2025 Jun 1;44(6):589-592.
doi: 10.1097/INF.0000000000004719. Epub 2025 Jan 7.

Improved Uptake of Vaccinations in Children With Adverse Events Following Immunization After Specialist Immunization Service Intervention in an Australian Pediatric Hospital

Jialin Sabrina Yee  1 , Rebecca Doyle  1   2 , Sophie Chien-Hui Wen  1   3
Affiliations

Improved Uptake of Vaccinations in Children With Adverse Events Following Immunization After Specialist Immunization Service Intervention in an Australian Pediatric Hospital

Jialin Sabrina Yee et al. Pediatr Infect Dis J. .

Abstract

Background: Adverse Events Following Immunization (AEFI) have significant implications for public health, potentially leading to decreased immunization rates and vaccine hesitancy. Understanding the characteristics and outcomes of children experiencing AEFI is crucial for effective intervention strategies and informed decision-making. This study aimed to describe the diverse range of AEFI presentations, identify common referral sources and assess factors influencing vaccination uptake following specialist consultation.

Methods: A single-center retrospective cohort study was conducted from 2019 to 2022, analyzing AEFI data from 191 children referred to a Specialist Immunization Service (SIS) at an Australian pediatric health service. Demographic data, referral details, vaccination history, and AEFI types were considered. Statistical analyses, including univariate and multivariate models, were employed to predict vaccination outcomes post-SIS consultation.

Results: The median age of children referred was 2 years. General practitioners were the major referral source (68%). Urticarial rash was the most prevalent AEFI referred (29%). Pneumococcal conjugate vaccine was the most implicated vaccine (38%). The majority (69%) were successfully vaccinated following SIS consultation with 3% experiencing a subsequent AEFI (all mild). Older age is found to be associated with less likelihood for vaccination (odds ratio = 0.93, 95% confidence interval: 0.88-0.99, P = 0.027). Formal reporting of AEFI was low (26%).

Conclusions: Severe adverse events, including anaphylaxis, were rare, and a SIS played an important role in vaccinating children following AEFI. Vaccination following urticarial rash is likely safe, and options such as a drop-in immunization center in a hospital setting may reduce delay to the next dose in scheduled vaccinations following AEFI. AEFI reporting needs to be promoted, and a patient-initiated reporting system may enhance this.

Keywords: adverse event following immunization; specialist immunization service; vaccination.

PubMed Disclaimer

Conflict of interest statement

The authors have no funding or conflicts of interest to disclose.

References

    1. Australian Technical Advisory Group on Immunisation (ATAGI). Australian Immunisation Handbook. Australian Government Department of Health and Aged Care, Canberra, 2022. Available at: http://immunisationhandbook.health.gov.au . Accessed September 16, 2023.
    1. Dey A, Wang H, Quinn H, et al. Surveillance of adverse events following immunisation in Australia annual report, 2020. Commun Dis Intell (2018). 2022;46. doi:10.33321/cdi.2023.47.47.
    1. Baxter CM, Clothier HJ, Perrett KP. Potential immediate hypersensitivity reactions following immunization in preschool aged children in Victoria, Australia. Hum Vaccin Immunother. 2018;14:2088–2092.
    1. Australian Technical Advisory Group on Immunisation (ATAGI). National Immunisation Program Schedule; Australian Government Department of Health and Aged Care, Canberra, 2023. Available at: https://www.health.gov.au/resources/publications/national-immunisation-p... . Accessed September 16, 2023.
    1. Erlewyn-Lajeunesse M, Hunt LP, Heath PT, et al. Anaphylaxis as an adverse event following immunisation in the UK and Ireland. Arch Dis Child. 2012;97:487–490.